Thermo Fisher Acquires Microbiological Testing Firm | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has acquired Trek Diagnostic Systems from Magellan Biosciences for an undisclosed amount.

Trek makes blood culture, microorganism identification, and antibiotic-susceptibility testing products for the pharmaceutical and clinical lab markets. The firm is based near Cleveland, has 150 employees, and had full-year 2010 revenues of $34 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.